Zolpidem and Imipramine Interaction

Understanding the Zolpidem and Imipramine Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Zolpidem belongs to the Non-Benzodiazepine Hypnotic (Z-Drug) class and Imipramine belongs to the Tricyclic Antidepressant (TCA) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both drugs slow down the central nervous system, which can lead to a combined effect that makes you feel much less alert. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Zolpidem has 9 total documented interactions on file in this dataset, and Imipramine has 20. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Be very careful when performing tasks that require focus and talk to your doctor about the risks of taking these together. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Zolpidem or Imipramine based on a web page, speak with your prescriber or pharmacist before making any change.